Bonesupport Holding

Board/Management Information • Nov 29, 2024

Change in BONESUPPORT's Nomination Committee ahead of the 2025 Annual General Meeting following a change in ownership

The composition of BONESUPPORT's Nomination Committee ahead of the 2025 Annual General Meeting was announced in the company's interim report for the third quarter on October 24 2024. As a result of a subsequent change in ownership, the composition of the Nomination Committee has changed with Anna Sundberg (appointed by Handelsbanken Fonder) leaving the Nomination Committee and Erik Selin (appointed by Erik Selin Fastigheter AB) joining as a new member of the Nomination Committee.

Accordingly, the Nomination Committee ahead of the 2025 Annual General Meeting consists of the following members:

• Caroline Sjösten, appointed by Swedbank Robur Fonder
• Erik Selin, appointed by Erik Selin Fastigheter
• Staffan Lindstrand, appointed by HealthCap

In addition, the Chairman of the Board of BONESUPPORT, Lennart Johansson, is co-opted to the Nomination Committee. The Nomination Committee has appointed Caroline Sjösten as Committee chair.

Shareholders wishing to submit proposals to the Nomination Committee may do so in writing to:

BONESUPPORT HOLDING AB Attn: Nomination Committee Scheelevägen 19 SE-223 70 Lund, Sweden

or by e-mail to legal@bonesupport.com.

For the Nomination Committee to consider and prepare a proposal, the proposal must be received well before the notice of the Annual General Meeting is published.

For more information contact:

BONESUPPORT Holding AB Emil Billbäck, CEO +46 (0) 46 286 53 70

Håkan Johansson, CFO +46 (0) 46 286 53 70 ir@bonesupport.com

Cord Communications Charlotte Stjerngren +46 (0) 708 76 87 87 charlotte.stjerngren@cordcom.se www.cordcom.se

About BONESUPPORT™

BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient's own bone and have the capability of eluting drugs. BONESUPPORT's bone graft substitutes are based on the patented technology platform CERAMENT. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver. The company is based in Lund, Sweden, and the net sales amounted to SEK 591 million in 2023. Please visit www.bonesupport. com for more information.

BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB.

Attachments

Change in BONESUPPORT's Nomination Committee ahead of the 2025 Annual General Meeting following a change in ownership